Skip to content

Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial)

Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202004693933092
Enrollment
200
Registered
2020-04-16
Start date
2020-04-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Sponsors

Misr University for Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Health care workers aged 18-50 years old

Exclusion criteria

Exclusion criteria: acute severe illness • recent receipt of a blood product • history of thrombocytopenia • Pregnant females • any chronic medical condition • Any participant receiving any immune suppressive medication • Immunocompromised staff • Participants who have egg allergy • Participants who care for immune-compromised hosts • Participants who test positive for COVID-19 serology prior to randomization

Design outcomes

Primary

MeasureTime frame
Serologic evidence of infection

Secondary

MeasureTime frame
Incidence of respiratory illness defined as two or more of the following o Fever o Sore throat o Dry cough o Runny nose o Shortness of breath ? Participants will be phoned weekly for assessment and reporting any symptoms and if participant complains of any respiratory symptom he will be evaluated clinically and COVID-19 PCR swab will be sent and if they test positive they will be treated as per national protocol and clinical outcome will be reported ? Incidence of admission to hospital

Countries

Egypt

Contacts

Public ContactMahmoud Nassar

investigator

dr.nassar@aucegypt.edu+201000037609

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026